for the Period Ended 29 May 2024
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 29 May 2024
Directors
The directors shown below have held office during the whole of the period from
30 May 2023
to
29 May 2024
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
2024 | 2023 | |
---|---|---|
|
£ |
£ |
Turnover: |
|
|
Cost of sales: |
(
|
|
Gross profit(or loss): |
|
|
Distribution costs: |
|
|
Administrative expenses: |
(
|
(
|
Operating profit(or loss): |
( |
( |
Profit(or loss) before tax: |
( |
( |
Profit(or loss) for the financial year: |
( |
( |
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Current assets | |||
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Creditors: amounts falling due within one year: | 3 |
(
|
(
|
Net current assets (liabilities): |
|
|
|
Total assets less current liabilities: |
|
|
|
Total net assets (liabilities): |
|
|
|
Members' funds | |||
Profit and loss account: |
|
|
|
Total members' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 29 May 2024
Basis of measurement and preparation
Turnover policy
for the Period Ended 29 May 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 29 May 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Other creditors |
|
|
Total |
|
|
The objectives of the company are to carry on activities which benefit the community and in particular, patients suffering with cardiac arrhythmia. Two arrhythmia consultants were sent to the Heart Rhythm Society Congress in the USA. Further equipment was purchased to produce a high-quality audio-visual system to allow live case broadcasting of ablation procedures so that other arrhythmia specialists can learn various procedures, including atrial and ventricular ablations and novel epicardial access techniques. Use of this system along with grant awards provides the main income for the Sussex Cardiac Centre EP CIC. New equipment was bought for the purpose of undertaking high frequency autonomic ganglia stimulation for arrhythmia research for patients within Sussex.
No consultation with stakeholders
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
27 February 2025
And signed on behalf of the board by:
Name: Dr John Silberbauer
Status: Director